Oruka Therapeutics (ORKA) Preferred Shares (2024 - 2026)

Oruka Therapeutics has reported Preferred Shares for 3 years, with the latest figure at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Preferred Shares changed 0.0% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (changed 0.0% YoY), and the FY2025 full-year result was $2.9 million, changed 0.0% from the prior year.
• Preferred Shares for Q1 2026 stood at $2.9 million, roughly flat from $2.9 million in the prior quarter.
• The five-year high for Preferred Shares was $2.9 million in Q3 2024, with the low at $2.9 million in Q3 2024.
• Average Preferred Shares over 3 years is $2.9 million, with a median of $2.9 million recorded in 2024.
• Peak annual rise in Preferred Shares reached 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
• Tracing ORKA's Preferred Shares over 3 years: stood at $2.9 million in 2024, then changed by 0.0% to $2.9 million in 2025, then changed by 0.0% to $2.9 million in 2026.
• The last three Preferred Shares figures came in at $2.9 million (Q1 2026), $2.9 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.

Peer Comparison